hepatitis
Information
- Disease name
- hepatitis
- Disease ID
- DOID:2237
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03089983 | Active, not recruiting | N/A | Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings | August 21, 2017 | May 2024 |
| NCT00004848 | Completed | A Controlled Prospective Study of Transfusion-Associated Hepatitis | July 1981 | May 2000 | |
| NCT00023309 | Completed | Phase 2 | Lamivudine and Adefovir to Treat Chronic Hepatitis B | August 2001 | August 2013 |
| NCT00039871 | Completed | Phase 3 | PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) | May 2002 | September 2007 |
| NCT00059397 | Completed | Hepatitis C: Grading and Staging by MR | April 2003 | ||
| NCT00062764 | Completed | Phase 2 | Treating Nonalcoholic Steatohepatitis With Pioglitazone | June 2003 | February 2009 |
| NCT00063232 | Completed | Phase 2 | Treating Nonalcoholic Steatohepatitis (NASH) With Metformin | June 2003 | March 2008 |
| NCT00076336 | Completed | Phase 3 | Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis | December 2003 | |
| NCT00080236 | Completed | Phase 2 | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | November 2003 | January 2006 |
| NCT00088504 | Completed | Phase 2 | Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C | July 2004 | October 2006 |
| NCT00108589 | Completed | Phase 3 | S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis | January 2004 | December 2006 |
| NCT00141999 | Completed | Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents | May 2001 | March 2008 | |
| NCT00144313 | Completed | Phase 4 | VaxTeen Hepatitis B Vaccine Booster Study | August 2005 | January 2006 |
| NCT00147784 | Completed | Phase 3 | HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. | March 2006 | January 2008 |
| NCT00160407 | Completed | Phase 4 | Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) | October 2003 | December 2006 |
| NCT00194480 | Completed | Phase 4 | Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users | April 2003 | June 2007 |
| NCT00218335 | Completed | Phase 2 | A Network & Dyad HIV Prevention Intervention for IDU's - 1 | June 2003 | May 2008 |
| NCT00224705 | Completed | Phase 3 | The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure | August 2004 | January 2009 |
| NCT00287469 | Completed | Phase 2 | A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. | July 9, 2001 | January 2005 |
| NCT00300209 | Completed | Manhattan HIV/Hepatology Brain Bank | September 1998 | June 2002 | |
| NCT00412763 | Completed | Phase 4 | Efficacy of Silymarin for Acute Hepatitis | July 2003 | October 2005 |
| NCT00001879 | Completed | Collections of Blood and Stool Samples in Patients With Acute Hepatitis | March 1999 | March 2001 | |
| NCT00564642 | Completed | N/A | Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity | November 2007 | April 2009 |
| NCT00575315 | Completed | HIV-HCV Coinfection: Impact of Immune Dysfunction | July 2004 | August 2014 | |
| NCT00591968 | Completed | N/A | Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community | January 2008 | March 2008 |
| NCT00594412 | Completed | N/A | MRI to Measure Liver Fat Content | December 20, 2007 | June 15, 2011 |
| NCT00679692 | Completed | Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease | September 2006 | March 2008 | |
| NCT05414552 | Completed | ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment | June 1, 2021 | December 30, 2022 | |
| NCT00901524 | Completed | Phase 2 | ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV | June 2009 | June 2012 |
| NCT00929786 | Completed | Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity | November 2007 | June 2009 | |
| NCT00987337 | Completed | Phase 2 | Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects | November 2009 | January 2012 |
| NCT01062321 | Completed | Role of Cytokines in Hepatitis E Virus Infection During Pregnancy | August 2009 | July 2012 | |
| NCT01068444 | Completed | Phase 2 | The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis | April 2009 | July 2020 |
| NCT01102296 | Completed | N/A | Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection | June 2009 | April 2012 |
| NCT04757272 | Completed | Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? | May 1, 2020 | July 30, 2022 | |
| NCT01159925 | Completed | Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children | July 2009 | December 2011 | |
| NCT01159951 | Completed | Analysis of Trends Over Time of Hepatitis Related Incidence in Panama | January 2009 | August 2011 | |
| NCT01163240 | Completed | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | June 2009 | ||
| NCT01390194 | Completed | Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma | July 1, 2011 | June 1, 2015 | |
| NCT04593355 | Completed | HCV Epidemiological Survey in China Rural Area | December 2009 | September 2012 | |
| NCT03685708 | Completed | Phase 2 | HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) | December 7, 2018 | December 16, 2020 |
| NCT03619590 | Completed | Twinrix Pregnancy Registry | May 18, 2001 | September 15, 2017 | |
| NCT01456845 | Completed | Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity | August 2010 | June 2012 | |
| NCT01641276 | Completed | N/A | Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma | April 2012 | June 2015 |
| NCT01645033 | Completed | N/A | Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients | April 2012 | December 2013 |
| NCT03509688 | Completed | N/A | The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial | November 2014 | December 2017 |
| NCT01725815 | Completed | N/A | The Health Access and Recovery Peer Program | June 2011 | March 31, 2017 |
| NCT01740089 | Completed | Phase 2/Phase 3 | Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C | November 2011 | December 2013 |
| NCT01889433 | Completed | Phase 3 | An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C | July 10, 2013 | December 2, 2015 |
| NCT03482388 | Completed | N/A | Crowdsourcing to Promote HBV and HCV Testing in China | May 9, 2018 | June 9, 2018 |
| NCT02103439 | Completed | Phase 3 | An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients | June 6, 2013 | August 26, 2015 |
| NCT02920931 | Completed | Phase 1 | A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers | February 2016 | April 2016 |
| NCT02126696 | Completed | Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho | May 2014 | December 2015 | |
| NCT02128217 | Completed | Phase 1 | Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection | May 30, 2014 | May 9, 2017 |
| NCT03480529 | Completed | Monitoring the IMmUological TOXicity of Drugs | March 1, 2018 | March 10, 2018 | |
| NCT03410953 | Completed | Phase 4 | Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines | April 13, 2018 | October 31, 2019 |
| NCT02368522 | Completed | Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU) | December 2014 | February 2017 | |
| NCT03119025 | Completed | Phase 1/Phase 2 | Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection | May 2015 | April 2018 |
| NCT02108444 | Completed | Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | January 2007 | March 2014 | |
| NCT06395129 | Not yet recruiting | Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries | September 2024 | December 2026 | |
| NCT05062967 | Not yet recruiting | Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease | January 1, 2022 | December 1, 2024 | |
| NCT05813691 | Not yet recruiting | Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative. | April 10, 2023 | April 10, 2025 | |
| NCT04595734 | Recruiting | Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. | January 7, 2020 | January 6, 2025 | |
| NCT06111859 | Recruiting | N/A | Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification | January 2, 2023 | July 2, 2025 |
| NCT02275195 | Recruiting | Immune Cell Dysfunction in Severe Alcoholic Hepatitis | November 2013 | December 2024 | |
| NCT05557448 | Recruiting | Phase 2 | To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose | May 1, 2023 | December 2026 |
| NCT05563961 | Recruiting | N/A | A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers | October 28, 2022 | December 2024 |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT05719480 | Recruiting | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer | November 20, 2022 | December 20, 2025 | |
| NCT05738681 | Recruiting | Phase 2/Phase 3 | Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial | September 9, 2022 | May 31, 2023 |
| NCT03692897 | Recruiting | An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection | October 11, 2018 | January 2026 | |
| NCT05989958 | Recruiting | Phase 1 | The Safety and Tolerability Study of HepaCure in Chinese Subjects With Acute-On-Chronic Liver Failure | September 22, 2023 | September 2024 |
| NCT06072287 | Recruiting | The Living With a Long-Term Condition Study | June 28, 2023 | January 10, 2024 | |
| NCT04306939 | Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study | November 1, 2014 | December 1, 2025 | |
| NCT02613403 | Terminated | Phase 2 | Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) | December 10, 2015 | March 27, 2017 |
| NCT00465842 | Terminated | Protein Biomarker in Hepatocellular Carcinoma | June 20, 2006 | August 14, 2013 | |
| NCT01443923 | Terminated | Phase 4 | Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV | September 2011 | September 2013 |
| NCT02764671 | Unknown status | Phase 4 | Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates | May 2015 | September 2020 |
| NCT03166943 | Unknown status | N/A | the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function | May 10, 2017 | December 2020 |
| NCT02342821 | Unknown status | Empowering Immigrants in the Greater Boston Area to Connect to HBV Care | February 2015 | June 2017 | |
| NCT02075242 | Unknown status | Phase 4 | TO Compare the Triple Drug Therapy and Dual Therapy . | January 2014 | January 2016 |
| NCT01724723 | Unknown status | Phase 4 | Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment | December 2012 | June 2014 |
| NCT01434212 | Unknown status | Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy | May 2010 | December 2011 | |
| NCT03776760 | Unknown status | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination | May 28, 2019 | August 2022 | |
| NCT01395654 | Unknown status | Phase 4 | Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment | July 2011 | December 2015 |
| NCT04618575 | Unknown status | Phase 4 | Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 | March 17, 2021 | November 5, 2022 |
| NCT01142882 | Unknown status | N/A | Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention | February 2010 | August 2011 |
| NCT04846010 | Unknown status | Phase 1/Phase 2 | Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 | March 1, 2021 | October 1, 2022 |
| NCT00815464 | Unknown status | N/A | A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B | March 2009 | March 2010 |
| NCT03085342 | Unknown status | N/A | Evaluation of Hepatic Fibrosis on Multiparametric MRI | April 4, 2017 | December 2021 |
- Disase is a (Disease Ontology)
- DOID:409
- Cross Reference ID (Disease Ontology)
- ICD10CM:K73.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:570
- Cross Reference ID (Disease Ontology)
- ICD9CM:571.4
- Cross Reference ID (Disease Ontology)
- ICD9CM:571.41
- Cross Reference ID (Disease Ontology)
- MESH:D006521
- Cross Reference ID (Disease Ontology)
- NCI:C82978
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155813004
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:197268000
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266539002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0001308
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0019189
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0149519
- Exact Synonym (Disease Ontology)
- acute and subacute liver necrosis
- Exact Synonym (Disease Ontology)
- acute hepatitis
- Exact Synonym (Disease Ontology)
- acute/subac. necrosis of liver
- Exact Synonym (Disease Ontology)
- animal hepatitis
- Exact Synonym (Disease Ontology)
- chronic hepatitis
- Exact Synonym (Disease Ontology)
- chronic persistent hepatitis
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0012115
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006505